ID   L6Cl2V1
AC   CVCL_UI12
SY   L6CL2V1
DR   Wikidata; Q95981059
RX   CelloPub=CLPUB00454;
RX   PubMed=6188627;
RX   PubMed=7297605;
CC   Selected for resistance to: UniProtKB; P02866; Canavalia ensiformis concanavalin-A.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_UI08 ! L6Cl2
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
RX   CelloPub=CLPUB00454;
RA   Spearman M.A.;
RT   "Studies on the effects of altered glycoprotein glycosylation on
RT   differentiation and metabolism of rat L6 myoblasts.";
RL   Thesis PhD (1988); University of Manitoba; Winnipeg; Canada.
//
RX   PubMed=6188627; DOI=10.1016/0014-4827(83)90420-2;
RA   Parfett C.L.J., Jamieson J.C., Wright J.A.;
RT   "Changes in cell surface glycoproteins on non-differentiating L6 rat
RT   myoblasts selected for resistance to concanavalin A.";
RL   Exp. Cell Res. 144:405-415(1983).
//
RX   PubMed=7297605; DOI=10.1016/0014-4827(81)90032-X;
RA   Parfett C.L.J., Jamieson J.C., Wright J.A.;
RT   "A correlation between loss of fusion potential and defective
RT   formation of mannose-linked lipid intermediates in independent
RT   concanavalin A-resistant myoblast cell lines.";
RL   Exp. Cell Res. 136:1-14(1981).
//